Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?

Free article

Comment

Bernt Gerhard Wikström. Eur J Heart Fail. 2010 Aug.

Free article

. 2010 Aug;12(8):893.

doi: 10.1093/eurjhf/hfq111.

No abstract available

Comment on

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A. Mebazaa A, et al. Eur J Heart Fail. 2009 Mar;11(3):304-11. doi: 10.1093/eurjhf/hfn045. Epub 2009 Jan 21. Eur J Heart Fail. 2009. PMID: 19158152 Free PMC article. Clinical Trial.
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
Omerovic E, Waagstein F, Swedberg K. Omerovic E, et al. Eur J Heart Fail. 2010 Apr;12(4):313-4. doi: 10.1093/eurjhf/hfq035. Eur J Heart Fail. 2010. PMID: 20335348 No abstract available.
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G. Bergh CH, et al. Eur J Heart Fail. 2010 Apr;12(4):404-10. doi: 10.1093/eurjhf/hfq032. Eur J Heart Fail. 2010. PMID: 20335355 Free PMC article. Clinical Trial.